TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study.

Yu Xue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.